Amgen Inc
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen Other Intangible Assets by Year
Other Intangible Assets — Total Net Carrying Value ($M) ($M)
Amgen Other Intangible Assets: $22,276M in FY2025, down 19.6% from a year earlier.
Latest, FY2025
22,276
Period ended Dec 31, 2025
Change on a year earlier
-19.6%
27,699 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Goodwill and Other Intangible Assets Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Intangible Assets — Total Net Carrying Value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22,276 | -19.6% | Form 10-Q (filed 2026-08-05) ↗ |
| FY2024 | Dec 31, 2024 | 27,699 | -15.1% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 32,641 | +103.0% | Form 10-K (filed 2025-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 16,080 | +5.9% | Form 10-K (filed 2024-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 15,182 | -8.5% | Form 10-K (filed 2023-02-09) ↗ |
| FY2020 | Dec 31, 2020 | 16,587 | -14.6% | Form 10-K (filed 2022-02-16) ↗ |
| FY2019 | Dec 31, 2019 | 19,413 | +160.8% | Form 10-Q (filed 2020-05-01) ↗ |
| FY2018 | Dec 31, 2018 | 7,443 | -13.5% | Form 10-Q (filed 2019-10-30) ↗ |
| FY2017 | Dec 31, 2017 | 8,609 | -16.2% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 10,279 | -11.7% | Form 10-K (filed 2018-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 11,641 | – | Form 10-K (filed 2017-02-14) ↗ |
Breakdown
What makes up other Intangible Assets
- Other Intangible Assets — Total Gross Carrying Value ($M)55,060 · FY2025
- Other Intangible Assets — Total Accumulated Amortization ($M)32,784 · FY2025
- Finite-Lived Intangible Assets — Total Net Carrying Value ($M)21,566 · FY2025
- Indefinite-Lived In-Process R&D (IPR&D) Intangible Assets ($M)710 · FY2025
- Intangible Asset Amortization Expense ($M)4,300 · FY2025
- Intangible Asset Impairment Charges ($M)1,200 · FY2025
- Total Depreciation and Amortization (Cash Flow Statement) ($M)5,167 · FY2025
Cite this data
StockData. (2026). Amgen Other Intangible Assets ($M), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/intang-net-tot
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.